by Jordana Choucair | Sep 20, 2021 | Payers
The CMS issued the third part of the 2022 Notice of Benefit and Payment Parameters, extending ACA open enrollment by another month. The new deadline on the federally run exchanges will be January 15. The rule increases insurer user fees for participating on the...
by Jordana Choucair | Sep 20, 2021 | Life Sciences
Pfizer Inc. and BioNTech SE said a late-stage clinical trial showed that their COVID-19 vaccine was safe and generated strong antibody responses in children 5 to 11 years old. However, the companies don’t yet know how well the shot protects against COVID-19 for...
by Jordana Choucair | Sep 20, 2021 | D.C. News
A group of Senate Democrats is looking at expanding a plan to penalize pharmaceutical companies that raise drug prices above the rate of inflation as part of the government spending package. Lawmakers are still crafting the bill and the details could change, but if...
by Jordana Choucair | Sep 17, 2021 | Public Health/Prevention
A new CDC report indicates that children and teens gained weight at an “alarming” rate during the pandemic, validating concerns school closures during the COVID-19 may have reduced regular physical activity and access to healthy meals. The average...
by Jordana Choucair | Sep 17, 2021 | Opioid/Substance Use Disorders
The Department of Justice (DOJ) filed a motion to block Purdue Pharma LP’s bankruptcy plan while the agency appeals a federal judge’s decision to approve the settlement. In the filing, William K. Harrington, the DOJ’s U.S. trustee, said the deal –...
Recent Comments